第一次持有人会议 北京市中洲律师事务所 关于中交地产股份有限公司 2021 年面向专业投资者公开发行公司债券 2025 年度 之 法律意见书 法律意见书 北京市中洲律师事务所 关于中交地产股份有限公司 2021 年面向专业投资者公开发行公司债券 2025 年度第一次债券持有人会议之 法律意见书 中洲法意字［2025］第 0519-1 号 致：中交地产股份有限公司 北京市中洲律师事务所（以下简称"本所"）接受中交地产股份有限公司（以 下简称"发行人"、"中交地产"）的委托，根据《中华人民共和国公司法》(以下 简称"《公司法》")、《中华人民共和国证券法》等法律法规、规范性文件以及《中 交地产股份有限公司 2021 年面向专业投资者公开发行公司债券募集说明书》(以 下简称"《募集说明书》")以及本期债券《债券持有人会议规则》(以下简称"《债 券持有人会议规则》")的相关规定、约定，按照中国律师行业公认的业务标准、 道德规范和勤勉尽责的精神，就中交地产公开发行的"中交地产股份有限公司 2021 年面向专业投资者公开发行公司债券"(以下简称"21 中交债"或"本期债 券")2025 年第一次债券持有人会议(以下简称" ...

Group 1 - Zhaoyi Innovation plans to issue H-shares and list on the Hong Kong Stock Exchange, considering the interests of existing shareholders and market conditions [3] - ST Zhongdi has decided to abandon the commercial opportunity for the Jiageng Science and Art City land project, which has an area of 108,600 square meters and a starting price of 2.067 billion yuan [4] - Xichang Electric Power expects a reduction of approximately 5.4 million yuan in net profit for 2025 due to adjustments in the time-of-use electricity pricing mechanism [5] Group 2 - Sanfu New Technology plans to invest 620 million yuan in a project for high-safety dry electrode battery key materials and high-frequency electronic information composite materials, with production expected to start in June 2025 [6] - Weifu High-Tech's subsidiary will establish a joint venture with Baolong Technology to expand the business of fully active suspension motor hydraulic pumps, with a registered capital of 400 million yuan [7] - Yulong Co., Ltd. will have its stock delisted on May 27, 2025, following a decision by the Shanghai Stock Exchange [8] Group 3 - Chensan Technology's shareholder Shanghai Ruiwei will transfer 14.58 million shares, representing 6.27% of the company, to Hefei Guotou, with the transfer price set at 17.7 yuan per share [10] - Huamao Technology is planning to acquire a 100% stake in Fuchuang Youyue, currently holding 42.16% of the company, with stock trading suspended for up to 10 days [11] - Baolong Technology's subsidiary will partner with Weifu High-Tech's subsidiary to develop and mass-produce core components for fully active suspension systems [12] Group 4 - Buchang Pharmaceutical's subsidiary has signed a commissioned research agreement with Fubicheng Pharmaceutical for the MF59 emulsion adjuvant [14] - Hongjing Technology has signed a service contract worth 597 million yuan for a smart computing project, with a duration of five years [15] - Zhuojin Co., Ltd. has won a bid for a soil remediation project worth 67.68 million yuan, with an expected share of approximately 59.9 million yuan [16] - Xinjiang Jiaojian has been awarded a contract for the G3013 line Ucha to Kangsou highway project, with a bid amount of 451 million yuan [17] Group 5 - Mingchen Health plans to repurchase shares worth between 30 million and 50 million yuan for employee stock ownership plans, with a maximum repurchase price of 23 yuan per share [19]

Group 1 - Hongjing Technology signed a service contract for an intelligent computing project with a total amount of 597 million yuan, valid for 5 years [1] - Weifu High-Tech's subsidiary invested 220 million yuan to establish a joint venture with Shanghai Baolong Automotive Technology [2] - Zhongshan Public received approval for the registration of short-term financing bonds amounting to 2 billion yuan and medium-term notes of 3 billion yuan [3] Group 2 - Lianhua Technology established a venture capital fund with a total commitment of 200 million yuan, contributing 100 million yuan as a limited partner [4] - Changan Technology's shareholder signed an agreement to transfer 6.27% of the company's shares to Hefei State Capital Venture Investment [6] - Hangzhou Garden announced a cash dividend of 0.5 yuan per 10 shares, totaling 6.62 million yuan [8] Group 3 - Huamao Technology plans to acquire 100% equity of Fuchuang Youyue, leading to a temporary suspension of its stock [9] - Zhuojin Co. won a bid for a soil remediation project in Hefei with a contract value of 67.68 million yuan [10] - Shanghai Pharmaceuticals received FDA approval for two drugs, enhancing its product portfolio [10] Group 4 - Fuxing Pharmaceutical's senior vice president resigned for personal reasons [12] - Baolong Technology's subsidiary plans to invest 180 million yuan in a joint venture [13] - ST Zhongdi intends to utilize surplus funds from a project company, with a maximum of 106 million yuan [14] Group 5 - Nanchao Food reported a significant decline in net profit for April, down 82.14% year-on-year [16] - Changshan Pharmaceutical received a drug registration certificate in Belarus for a new product [18] - Nanshan Aluminum established a wholly-owned subsidiary for photovoltaic energy projects with an investment of 5 million yuan [20] Group 6 - Bozhong Precision announced the resignation of a director and deputy general manager [22] - Xinjiang Jiaojian won a bid for a highway construction project valued at 451 million yuan [23] - Guangzhou Restaurant declared a cash dividend of 0.48 yuan per share, totaling 273 million yuan [25] Group 7 - Weili Medical's subsidiary obtained a medical device operating license, allowing it to engage in wholesale activities [27] - New Australia Co. announced a cash dividend of 0.3 yuan per share, totaling 219 million yuan [28] - Lianhua Technology's subsidiary entered the new third board innovation layer [29] Group 8 - Huaxi Energy's chairman resigned due to personal reasons [31] - Yipin Hong plans to use up to 500 million yuan of idle funds for cash management [33] - Shouhua Gas intends to purchase bauxite resources through market means [34] Group 9 - Jincheng signed a service agreement for underground mining operations at the Komakau Copper Mine, valued at approximately 805 million USD [34] - Wanrun New Energy signed a supply contract with CATL for lithium iron phosphate products, with a total supply of about 1.32 million tons [35] - Weili plans to transfer 100% equity of a subsidiary to Chengfa Environment for 100 million yuan [36] Group 10 - Zhenlei Technology's subsidiary received government subsidies of 2.21 million yuan, positively impacting profits [38] - Weir shares plan to change their name to "Haowei Group" to reflect strategic direction [39] - YTO Express reported a revenue increase of 16.32% in April, totaling 5.755 billion yuan [39]

Core Viewpoint - The company plans to jointly utilize surplus funds from the project company Kunming Zhongjiao Jinsheng Real Estate Co., Ltd. with its partners, with the company intending to call up to 105.56 million yuan and partners up to 184.74 million yuan [1][2]. Summary by Sections Overview of Fund Utilization - The company and its partners typically establish project companies for real estate development, combining equity and shareholder loans to meet operational funding needs. When surplus funds are available, partners usually utilize these funds proportionally to enhance capital efficiency [1]. Basic Situation of Fund Utilization - The company holds a 36.4% equity stake in Kunming Jinsheng, while Kunming Jindi Yunsheng Real Estate Development Co., Ltd. holds 33.6%, and Zhongjiao Yunnan Construction Investment Development Co., Ltd. holds 30%. The total amount to be called from Kunming Jinsheng is capped at 29.03 million yuan, with the company calling up to 10.56 million yuan [2][4]. Board of Directors' Review - The company's board approved the proposal to utilize surplus funds with a unanimous vote of 9 in favor, 0 against, and 0 abstentions during the meeting held on May 20, 2025 [2]. Basic Information of Project Company - Kunming Zhongjiao Jinsheng Real Estate Co., Ltd. was established on December 8, 2017, with a registered capital of 100 million yuan. The company is engaged in real estate development and related services [4]. Financial Indicators of Kunming Jinsheng - The project under development, Kunming Zhongjiao Jindi Central Park, covers an area of 65,463 square meters with a total construction area of 323,953 square meters. As of December 2024, the total investment in the project reached 3.913 billion yuan [4]. Financial Assistance Risk Control Measures - The operational status of Kunming Jinsheng is normal, and the fund utilization will not affect its development and operations. The company will closely monitor the financial and operational changes of Kunming Jinsheng and its partners to manage risks effectively [8]. Purpose of Financial Assistance and Impact on the Company - The fund utilization is equitable among partners, ensuring equal rights and obligations, which is beneficial for the company's business development and will not harm the interests of the company or its shareholders [9]. Commitment Regarding Fund Utilization - The company commits not to use idle raised funds for temporary liquidity support or to change the purpose of raised funds within twelve months after providing financial assistance [9]. Cumulative Financial Assistance Provided - As of April 30, 2025, the company has provided a cumulative financial assistance balance of 2.28 billion yuan, with shareholder loans to related real estate project companies amounting to 3.728 billion yuan, representing 104% of the company's audited net assets as of the end of 2024 [9].

独立董事： 刘洪跃、唐国平、谭敬慧 2025 年 5 月 19 日 2 1 规定；考虑到公司实际状况，在现阶段放弃此次商业机会，有利于公 司稳健经营，对公司财务状况和经营成果无重大影响，没有损害公司 利益或中小股东利益的情况。 独立董事同意将本项关联交易议案提交公司董事会审议。 中交地产股份有限公司第十届董事会 独立董事专门会议 2025 年第二次会议审核意见 根据《上市公司独立董事管理办法》、《深圳证券交易所股票上市规 则》、中交地产股份有限公司（以下简称"中交地产"）《独立董事工 作制度》等有关规定，中交地产独立董事于 2025 年 5 月 19 日召开了 第十届董事会独立董事专门会议 2025 年第二次会议，独立董事本着 实事求是、认真负责的态度，基于独立判断的立场，对中交地产第十 届董事会第三次会议审议的《关于放弃相关项目商业机会的关联交易 议案》进行了认真的事前审核，并发表审核意见如下： 中交地产于近期获悉厦门市集美区 J2025P01 号嘉庚科艺城地块 项目的商业机会，项目位于厦门市集美区，土地面积 10.86 万平方米， 土地用途为商住用地，计容建筑面积约 17.40 万平方米，项目挂牌起 始价 ...

一、与合作方调用项目公司富余资金情况概述 （一）简述 | 证券代码：000736 | 证券简称：*ST | 中地 | 公告编号：2025-059 | | --- | --- | --- | --- | | 债券代码：149610 | 债券简称：21 | 中交债 | | | 债券代码：148385 | 债券简称：23 | 中交 | 04 | | 债券代码：148551 | 债券简称：23 | 中交 | 06 | | 债券代码：134164 | 债券简称：25 | 中交 | 01 | | 债券代码：133965 | 债券简称：25 | 中交 | 02 | | 债券代码：134197 | 债券简称：25 | 中交 | 03 | 中交地产股份有限公司 关于与合作方共同调用项目公司富余资金的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 重要内容提示： 中交地产股份有限公司（以下简称"公司"）拟与合作方按合作 比例共同调用昆明中交金盛置业有限公司（以下简称"昆明金盛"） 富余资金，其中公司拟调用不超过 10,556 万元，合作方拟调用合计 不超过 18,474 万 ...

| 证券代码：000736 | 证券简称：*ST | 中地 | | 公告编号：2025-058 | | --- | --- | --- | --- | --- | | 债券代码：149610 | 债券简称：21 | 中交债 | | | | 债券代码：148385 | 债券简称：23 | 中交 | 04 | | | 债券代码：148551 | 债券简称：23 | 中交 | 06 | | | 债券代码：134164 | 债券简称：25 | 中交 | 01 | | | 债券代码：133965 | 债券简称：25 | 中交 | 02 | | | 债券代码：134197 | 债券简称：25 | 中交 | 03 | | 中交地产股份有限公司 关于放弃相关项目商业机会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 一、放弃商业机会概述 中交地产股份有限公司（以下简称"公司"）于近期获悉厦门市 集美区 J2025P01 号嘉庚科艺城地块项目的商业机会，项目位于厦门 市集美区，土地面积 10.86 万平方米，土地用途为商住用地，计容建 筑面积约 17.40 万平方米，项 ...

| 证券代码：000736 | 证券简称：*ST | 中地 | | 公告编号：2025-060 | | --- | --- | --- | --- | --- | | 债券代码：149610 | 债券简称：21 | 中交债 | | | | 债券代码：148385 | 债券简称：23 | 中交 | 04 | | | 债券代码：148551 | 债券简称：23 | 中交 | 06 | | | 债券代码：134164 | 债券简称：25 | 中交 | 01 | | | 债券代码：133965 | 债券简称：25 | 中交 | 02 | | | 债券代码：134197 | 债券简称：25 | 中交 | 03 | | 中交地产股份有限公司 关于召开 2025 年第四次临时股东大会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 一、召开会议的基本情况 （一）股东大会届次：2025 年第四次临时股东大会。 （二）召集人：经公司第十届董事会第三次会议审议通过，由公 司董事会召集本次股东大会。 （三）本次股东大会会议召开符合公司《章程》及有关法律、行 政法规等的规定。 ...

| 证券代码：000736 | 证券简称：*ST | 中地 公告编号：2025-057 | | --- | --- | --- | | 债券代码：149610 | 债券简称：21 | 中交债 | | 债券代码：148385 | 债券简称：23 | 中交 04 | | 债券代码：148551 | 债券简称：23 | 中交 06 | | 债券代码：134164 | 债券简称：25 | 中交 01 | | 债券代码：133965 | 债券简称：25 | 中交 02 | | 债券代码：134197 | 债券简称：25 | 中交 03 | 中交地产股份有限公司第十届董事会 第三次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 关联董事郭主龙、薛四敏、王尧、杨光泽、陈玲回避表决本项议 案。 本项议案需提交公司股东大会审议。 二、以 9 票同意、0 票反对、0 票弃权的表决结果审议通过《关 于与合作方共同调用项目公司富余资金的议案》。 本项议案详细情况于 2025 年 5 月 21 日在《中国证券报》、《证 券时报》、《上海证券报》、《证券日报》和巨潮资讯网上 ...

| 债券代码：149610 | 债券简称：21 | 中交债 | | | --- | --- | --- | --- | | 债券代码：148385 | 债券简称：23 | 中交 | 04 | | 债券代码：148551 | 债券简称：23 | 中交 | 06 | | 债券代码：134164 | 债券简称：25 | 中交 | 01 | | 债券代码：133965 | 债券简称：25 | 中交 | 02 | | 债券代码：134197 | 债券简称：25 | 中交 | 03 | 国新证券股份有限公司 关于中交地产股份有限公司涉及重大诉讼（仲裁）的 临时受托管理事务报告 国新证券股份有限公司（以下简称"国新证券"）编制本报告的内容及 信息均来源于中交地产股份有限公司（以下简称"中交地产"或"发行人"） 对外披露的相关公开信息披露文件、第三方中介机构出具的专业意见以及发 行人向国新证券出具的说明文件。 （四）案件的基本情况 本报告不构成对投资者进行或不进行某项行为的推荐意见，投资者应对 相关事宜作出独立判断，而不应将本报告中的任何内容据以作为国新证券所 作的承诺或声明。 国新证券股份有限公司作为中交地产发行的"21 ...